Clinical Trials

Phase 3 Active not recruiting

Dendritic Cell Sarcoma, Interdigitating

NCT03784014 2025-12-11

MULTISARC

603 enrolled

Neoplasm Metastasis, Sarcoma

NCT07264296 2025-12-04

IRISSAR

Enrolling by invitation

40 enrolled

Osteosarcoma, Prosthesis-Related Infections

NCT03546127 2025-09-11

MULTIPLI-0

Completed

24 enrolled

GastrointestinalSarcoma

Sarcoma, Colorectal Neoplasms

NCT06749600 2025-06-18

POLMS

Recruiting

Phase NA Enrolling by invitation

Neoplasms, Neoplasms by Histologic Type, Neoplasms, Muscle Tissue, Sarcoma, Neoplasms, Connective and Soft Tissue

NCT06968884 2025-05-13

Application of a Comprehensive Protocol Aimed at Reducing the Risk of Complications After Surgery for Sarcoma. Interventions Before, During and After Surgery for Known and Presumed Risk Factors Compared to Standard of Care in a Total of 300 Patients.

300 enrolled

Sarcoma, Risk Reduction Behavior

NCT03670927 2024-11-07

Bone Neoplasms

NCT05615545 2024-02-07

Cryoablation for Advanced Bone and Soft Tissue Tumors

NCT05718778 2024-02-07

Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma

31 enrolled

NCT06217224 2024-01-22

PBMT/MTX

53 enrolled

Osteosarcoma, Stomatitis

NCT05490667 2023-10-30

Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor

Desmoid Tumors

NCT05827458 2023-04-25

TOSS

Completed

500 enrolled

Bone Neoplasms, Neoplasms, Sarcoma, Soft Tissue Neoplasms

NCT05747521 2023-02-28

Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma

85 enrolled

NCT05475938 2022-07-29

Application of Painting Analysis and Psychotherapy in Children With Bone Tumors

Phase NA Completed

40 enrolled

Bone Neoplasms

NCT04223583 2022-03-16

Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule

Phase 4 Completed

70 enrolled

NCT03296553 2022-01-27

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

Phase 2 Completed

40 enrolled 6 charts

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Immune Reconstitution Inflammatory Syndrome

NCT04746001 2021-11-11

AIortho

100 enrolled

Bone Neoplasms

NCT00841152 2021-03-16

BAGvsTCP

Completed

120 enrolled

Bone Neoplasms

NCT04364724 2020-04-28

CTFEA Myeloma Study

200 enrolled

Plasma cellSarcoma

Bone Neoplasms, Fractures, Spontaneous, Multiple Myeloma, Disease Progression

NCT04344847 2020-04-14

Incidental Finding of Gastrointestinal Stromal Tumors (GISTs) During Laparoscopic Sleeve Gastrectomy, How to Deal? How Much Safety Margin

338 enrolled

GastrointestinalSarcoma

Margins of Excision, Gastrointestinal Stromal Tumors

NCT04158414 2019-11-08

Applying PET/MR in Oncology - a Prospective Project

GastrointestinalGenitourinaryGynecologicHead & NeckLymphoidSarcoma

500 enrolled

Uterine Cervical Neoplasms, Esophageal Neoplasms, Lymphoma, Nasopharyngeal Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT03390946 2018-01-09

Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma

23 enrolled

Osteosarcoma

NCT02982486 2017-11-01

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

60 enrolled

GastrointestinalSarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Osteosarcoma, Gastrointestinal Stromal Tumors, Desmoplastic Small Round Cell Tumor

NCT03163381 2017-05-23

Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.

40 enrolled

Osteosarcoma

NCT03106675 2017-04-24

MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases

Bone Neoplasms

NCT02430363 2016-02-24

Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475

Phase 1/2 Unknown

58 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT01296815 2015-07-27

Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity

Phase 2 Completed

14 enrolled 7 charts

Sarcoma, Kaposi

NCT01380275 2014-09-25

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

35 enrolled

Recurrence, Sarcoma

NCT01898416 2013-10-31

Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors

Phase 2 Recruiting

140 enrolled

The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an

NCT01412515 2012-01-02

A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma

Phase 2 Terminated

11 enrolled

Sarcoma, Kaposi

NCT00689195 2011-06-23

OSCAT

Phase 1/2 Unknown

24 enrolled

Osteosarcoma

NCT00691236 2011-06-23

ZOL

Phase 2/3 Unknown

60 enrolled

Osteosarcoma

NCT01304121 2011-06-16

Bioactive Glass Granules in Filling of Bone Defects

Phase 4 Completed

48 enrolled

Bone Neoplasms

NCT00687778 2008-06-02

11C-Acetate PET/CT Non-FDG-Avid Tumors

EndocrineGastrointestinalHead & NeckNETSarcomaThoracic

100 enrolled

Carcinoma, Hepatocellular, Lung Neoplasms, Sarcoma, Teratoma, Thyroid Neoplasms, Carcinoma, Lobular, Neuroendocrine Tumors

NCT00127569 2007-01-12

Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy

Phase 2 Terminated

25 enrolled

LymphoidSarcoma

Castleman Disease, Sarcoma, Kaposi, HIV Infections

NCT00339118 2006-06-20

EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children

Phase 4 Unknown